Cancidas (previously Caspofungin MSD) Den europeiske union - norsk - EMA (European Medicines Agency)

cancidas (previously caspofungin msd)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika for systemisk bruk - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

Trimonil Retard 300 mg Norge - norsk - Statens legemiddelverk

trimonil retard 300 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 300 mg

Trimonil Retard 600 mg Norge - norsk - Statens legemiddelverk

trimonil retard 600 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 600 mg

Verzenios Den europeiske union - norsk - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - bryst neoplasms - antineoplastiske midler - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Ambrisentan Accord 10 mg Norge - norsk - Statens legemiddelverk

ambrisentan accord 10 mg

accord healthcare b.v. - ambrisentan - tablett, filmdrasjert - 10 mg

Ambrisentan Accord 5 mg Norge - norsk - Statens legemiddelverk

ambrisentan accord 5 mg

accord healthcare b.v. - ambrisentan - tablett, filmdrasjert - 5 mg

Neurontin 300 mg Norge - norsk - Statens legemiddelverk

neurontin 300 mg

upjohn eesv - gabapentin - kapsel, hard - 300 mg

Neurontin 100 mg Norge - norsk - Statens legemiddelverk

neurontin 100 mg

upjohn eesv - gabapentin - kapsel, hard - 100 mg

Neurontin 400 mg Norge - norsk - Statens legemiddelverk

neurontin 400 mg

upjohn eesv - gabapentin - kapsel, hard - 400 mg

Neurontin 600 mg Norge - norsk - Statens legemiddelverk

neurontin 600 mg

upjohn eesv - gabapentin - tablett, filmdrasjert - 600 mg